All news and updates
News, articles and events from Mavatar, newest first.
Event · · Stockholm, Sweden
The Scariest Numbers in Drug Development: A Mavatar Science & Halloween Soirée
An afternoon on better decisions in drug development, with Danuta Gawel, and a panel with researchers and industry representatives, with Halloween drinks and food to follow.
Article · · Camila Guerrero De Blois, PhD
Computational biology as risk reduction in pharma R&D: an interview with Danuta Gawel
Why programs still reach Phase II on limited evidence, and four things R&D leaders can change on Monday.
Article · · Camila Guerrero De Blois, PhD
Curated vs Data-Derived Evidence in AI Drug Discovery
AI drug discovery tools claim to show their evidence, but from where? Compare curated knowledge with data-derived evidence and why the source matters
News ·
Mavatar enters research collaboration with Clínica Universidad de Navarra on Acute Myeloid Leukemia
Network-based transcriptomics applied to validate candidate biomarkers and explore biological relationships in AML.
Event · – · Stockholm, Sweden
EHA2026 Congress
The European Hematology Association Congress is one of the most important gatherings in hematology research, bringing together thousands of clinicians and scientists from across the world. This year it comes to Stockholm, and so do we.
Article · · Camila Guerrero De Blois, PhD
Beyond differential expression: How gene networks reveal real biology
Public repositories already hold the answers to many biological questions. The challenge is turning expression data into biology. This article explains how co-expression networks built across many independent studies reveal how genes work together, and how they turn a long list of differentially expressed genes into a few biological programs you can interpret.
Event · · Online
A webinar on understanding Alzheimer's disease at a systems level
Alzheimer’s disease is one of the most complex challenges in neurodegenerative disease research, not because we lack data, but because the biology is difficult to connect.
News ·
Mavatar Launches Alzheimer's Disease Networks at AD/PD 2026
Mavatar today announced the addition of networks of Alzheimer’s disease, glioma and other neurological disorders to its research platform, Mavatar Discovery, enabling researchers and pharmaceutical scientists to explore neurodegenerative disease biology at a systems level. The new resource will be formally introduced to the scientific at the AD/PD International Conference on Alzheimer's and Parkinson's Diseases taking place in Copenhagen from March 17–21, 2026.
Event · – · Copenhagen, Denmark
Mavatar at AD/PD Conference
Mavatar will be present at the AD/PD Conference in Copenhagen, March 17–21.
News ·
Mavatar delivers new data-driven resources to advance precision medicine for IBD
Mavatar, a global specialist in AI and data-driven precision medicine solutions, announces a key milestone in its contribution to the national project “Precision Medicine in Inflammatory Bowel Disease (IBD)”, funded by Vinnova. The company has developed an integrated transcriptomic resource designed to support a broad range of studies within precision medicine for patients with IBD.
News · Press release
Mavatar Launches Rare Disease Discovery Award
Awarded quarterly through 2026, the Mavatar Rare Disease Discovery Award gives researchers a one-year, full-access license to Mavatar Discovery to study rare diseases where data is scarce.
News · Press release
Mavatar enters research collaboration with Sobi
Mavatar, a global specialist in AI- and data-driven precision medicine solutions, today announces the start of a non-clinical research collaboration with Sobi, a global biopharmaceutical company focused on rare diseases.